Herpes Research Today is a free monthly online journal that collates and summarizes the latest research about Herpes, including details on herpes simplex virus (hsv), genital, oral, symptoms, treatment.

Volume 2 (2005), Issue 4 (April)

1. Active intranuclear movement of herpesvirus capsids.
   Nat Cell Biol, 7(4): 429-31. [Abstract] [Full-text]
2. Requirements for the upregulation of interleukin-6 by herpes simplex virus-infected gingival fibroblasts.
   Viral Immunol, 18(1): 170-8. [Abstract] [Full-text]
3. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
   Cancer Res, 65(7): 2832-9. [Abstract] [Full-text]
4. Primary cutaneous plasmacytoma: a role for a triggering stimulus?
   Clin Exp Dermatol, 30(3): 229-31. [Abstract] [Full-text]
5. Efficacy of Listerine Antiseptic in reducing viral contamination of saliva.
   J Clin Periodontol, 32(4): 341-6. [Abstract] [Full-text]
6. Sequencing and resolution of amplified herpes simplex virus DNA with intermediate melting curves as genotype 1 or 2 by LightCycler PCR assay.
   J Clin Microbiol, 43(4): 1843-5. [Abstract] [Full-text]
7. Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.
   Gene Ther, 12(8): 647-54. [Abstract] [Full-text]
8. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
   Exp Neurol, 193(1): 1-18. [Abstract] [Full-text]
9. Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin.
   J Virol, 79(9): 5863-9. [Abstract] [Full-text]
10. Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.
    J Virol, 79(9): 5272-7. [Abstract] [Full-text]
11. Evaluation of some pyrazoloquinolines as inhibitors of herpes simplex virus type 1 replication.
    Arch Pharm (Weinheim), 338(2): 74-7. [Abstract] [Full-text]
12. DNA polymerase gene locus of Cercopithecine herpesvirus 1 is a suitable target for specific and rapid identification of viral infection by PCR technology.
    Virus Genes, 30(3): 307-22. [Abstract] [Full-text]
13. Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase.
    Cancer Gene Ther, 12(5): 487-96. [Abstract] [Full-text]
14. Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.
    J Infect Dis, 191(10): 1734-46. [Abstract] [Full-text]
15. Factors that limit the effectiveness of herpes simplex virus type 1 for treatment of oral cancer in mice.
    Clin Cancer Res, 11(8): 3109-16. [Abstract] [Full-text]
16. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
    Proc Natl Acad Sci U S A, 102(16): 5838-43. [Abstract] [Full-text]
17. DNA repair proteins affect the lifecycle of herpes simplex virus 1.
    Proc Natl Acad Sci U S A, 102(16): 5844-9. [Abstract] [Full-text]
18. Recurrent herpes simplex virus type 2 infection of the hand complicated by persistent lymphoedema.
    Australas J Dermatol, 46(2): 110-3. [Abstract] [Full-text]
19. Oral herpes simplex reactivation after intrathecal morphine: a prospective randomized trial in an obstetric population.
    Anesth Analg, 100(5): 1472-6, table of contents. [Abstract] [Full-text]
20. Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties.
    Bioorg Med Chem, 13(10): 3371-8. [Abstract] [Full-text]
21. Detection and typing of herpes simplex DNA in genital swabs by real-time polymerase chain reaction.
    J Virol Methods, 126(1): 203-6. [Abstract] [Full-text]
22. Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus.
    Vaccine, 23(27): 3526-34. [Abstract] [Full-text]
23. Development of an HSV-tk transgenic mouse model for study of liver damage.
    FEBS J, 272(9): 2207-15. [Abstract] [Full-text]
24. Seroprevalence of HSV-1 and HSV-2 in Barbados.
    Med Microbiol Immunol (Berl), 194(1): 105-7. [Abstract] [Full-text]
25. The locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal Ganglia of acutely infected mice.
    J Virol, 79(10): 6162-71. [Abstract] [Full-text]
26. Structural basis for the physiological temperature dependence of the association of VP16 with the cytoplasmic tail of herpes simplex virus glycoprotein H.
    J Virol, 79(10): 6134-41. [Abstract] [Full-text]
27. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation.
    J Ocul Pharmacol Ther, 21(2): 114-20. [Abstract] [Full-text]
28. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
    J Leukoc Biol, 77(5): 661-8. [Abstract] [Full-text]

© 2004-2008 Herpes Research Today. All Rights Reserved.